Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18819040 | Medicament Delivery Device | August 2024 | April 2025 | Allow | 7 | 1 | 0 | Yes | No |
| 18799903 | Method of Joining Sterile Connectors | August 2024 | December 2024 | Allow | 4 | 1 | 0 | Yes | No |
| 18666217 | FLUIDICS CONTROL SYSTEM FOR MULTI CATHETER STACK | May 2024 | March 2025 | Allow | 10 | 2 | 1 | No | No |
| 18560984 | SYSTEM AND METHOD FOR DETECTING FLUID TYPE IN TUBING FOR FLUID INJECTOR APPARATUS | November 2023 | October 2024 | Allow | 11 | 2 | 0 | No | No |
| 18031537 | A CONNECTOR | April 2023 | August 2024 | Allow | 16 | 2 | 0 | Yes | No |
| 18157184 | PESSARY SYSTEM AND METHOD FOR PELVIC FLOOR LIGAMENT SUPPORT | January 2023 | March 2025 | Allow | 26 | 1 | 0 | Yes | No |
| 18059618 | Palm Activated Drug Delivery Device | November 2022 | May 2025 | Allow | 30 | 2 | 0 | Yes | No |
| 17822975 | METHODS AND DEVICES FOR VASCULAR ACCESS | August 2022 | April 2024 | Abandon | 19 | 3 | 0 | No | Yes |
| 17822006 | Reinforced Balloon Catheter | August 2022 | August 2024 | Allow | 24 | 2 | 0 | Yes | No |
| 17871460 | BODY CAVITY IRRIGATION AND DRAINAGE SYSTEM | July 2022 | September 2024 | Allow | 26 | 2 | 0 | Yes | No |
| 17868833 | METHOD AND DEVICE FOR THE ENHANCEMENT OF TOPICAL TREATMENTS FOR ORAL MUCOSITIS AND OTHER ORAL CONDITIONS | July 2022 | November 2024 | Abandon | 28 | 1 | 0 | No | No |
| 17869570 | MEDICAMENT DELIVERY DEVICES FOR ADMINISTRATION OF A MEDICAMENT WITHIN A PREFILLED SYRINGE | July 2022 | May 2025 | Allow | 33 | 2 | 0 | Yes | No |
| 17864528 | ENDOSCOPIC BENDABLE TUBE, ENDOSCOPE, AND METHOD OF MANUFACTURING ENDOSCOPIC BENDABLE TUBE | July 2022 | November 2023 | Allow | 17 | 1 | 1 | Yes | No |
| 17852470 | DICLOFENAC AND HYALURONIC ACID COMBINATION TREATMENT FOR ORAL LEUKPOPLAKIA | June 2022 | March 2025 | Abandon | 32 | 2 | 0 | No | No |
| 17839197 | APPARATUS AND METHODS FOR ACCESSING THE LYMPHATIC SYSTEM | June 2022 | November 2024 | Allow | 29 | 1 | 1 | No | No |
| 17828055 | PHARMACEUTICAL SYRINGE PISTON | May 2022 | January 2023 | Allow | 7 | 1 | 0 | No | No |
| 17729811 | NASAL IRRIGATION ASSEMBLY AND SYSTEM | April 2022 | November 2024 | Abandon | 31 | 2 | 0 | No | No |
| 17659237 | VALVE FOR DILATOR AND SHEATH ASSEMBLY | April 2022 | May 2025 | Allow | 37 | 4 | 0 | Yes | Yes |
| 17653352 | INJECTION ANALGESIA SYSTEM | March 2022 | December 2024 | Allow | 33 | 3 | 0 | Yes | No |
| 17636752 | METHOD AND APPARATUS FOR DELIVERY OF CELL THERAPIES | February 2022 | November 2024 | Abandon | 33 | 4 | 0 | No | No |
| 17651410 | PESSARY SYSTEM AND METHOD FOR PELVIC FLOOR LIGAMENT SUPPORT | February 2022 | August 2022 | Allow | 6 | 1 | 0 | Yes | No |
| 17549672 | System and method for plaque serration | December 2021 | September 2022 | Allow | 9 | 2 | 0 | Yes | No |
| 17546092 | STIMULATION OF PENIS ERECTION | December 2021 | October 2024 | Abandon | 34 | 2 | 0 | No | No |
| 17510078 | BENEFICIAL AGENT DISPENSER | October 2021 | July 2024 | Abandon | 33 | 2 | 0 | No | No |
| 17510068 | BENEFICIAL AGENT DISPENSER | October 2021 | July 2024 | Abandon | 33 | 2 | 0 | No | No |
| 17503720 | DIABETES MANAGEMENT SYSTEM WITH AUTOMATIC BASAL AND MANUAL BOLUS INSULIN CONTROL | October 2021 | April 2024 | Allow | 30 | 1 | 0 | No | No |
| 17498792 | METHOD AND DEVICE FOR THE ENHANCEMENT OF TOPICAL TREATMENTS FOR ORAL MUCOSITIS AND OTHER ORAL CONDITIONS | October 2021 | March 2025 | Abandon | 41 | 1 | 0 | No | No |
| 17494640 | INTRAVASCULAR DEVICE | October 2021 | November 2024 | Allow | 37 | 3 | 0 | Yes | No |
| 17490136 | SYSTEM AND METHOD FOR LAUNCHING USAGE MODE IN A MULTIMODAL SURGICAL GAS DELIVERY SYSTEM | September 2021 | February 2024 | Allow | 28 | 3 | 0 | Yes | No |
| 17491390 | VENTRICULAR UNLOADING SYSTEM | September 2021 | September 2024 | Allow | 35 | 3 | 0 | Yes | No |
| 17478546 | MEDICAMENT INJECTION DEVICE | September 2021 | July 2024 | Allow | 34 | 3 | 0 | Yes | No |
| 17464993 | EMBOLIZATION MICROCATHETER HEAD HAVING SLITTED PATTERN | September 2021 | January 2024 | Allow | 28 | 1 | 0 | Yes | No |
| 17412063 | METHOD OF PRODUCING SUBSTANCES WITH SUPERSATURATED GAS, TRANSDERMAL DELIVERY DEVICE THEREOF, AND USES THEREOF | August 2021 | April 2025 | Allow | 44 | 3 | 0 | No | No |
| 17404272 | System For Syringe Engagement To An Injector | August 2021 | March 2022 | Allow | 7 | 1 | 0 | No | No |
| 17397912 | FILTER CARTRIDGE ASSEMBLIES FOR MANAGING FLUID AND HUMIDITY IN ENDOSCOPIC SURGERY | August 2021 | August 2024 | Abandon | 37 | 3 | 0 | Yes | No |
| 17389894 | SYSTEM AND METHOD FOR PLAQUE SERRATION | July 2021 | November 2021 | Allow | 4 | 1 | 0 | No | No |
| 17390091 | SYSTEM AND METHOD FOR PLAQUE SERRATION | July 2021 | November 2021 | Allow | 4 | 1 | 0 | No | No |
| 17388554 | NON-OCCLUDING BALLOON FOR CARDIOVASCULAR DRUG DELIVERY | July 2021 | September 2023 | Allow | 26 | 1 | 0 | No | No |
| 17374740 | CONTINUOUS ANESTHESIA NERVE CONDUCTION APPARATUS, SYSTEM AND METHOD THEREOF | July 2021 | July 2024 | Abandon | 37 | 4 | 0 | Yes | Yes |
| 17374733 | CONTINUOUS ANESTHESIA NERVE CONDUCTION APPARATUS, SYSTEM AND METHOD THEREOF | July 2021 | April 2024 | Abandon | 33 | 3 | 1 | No | Yes |
| 17372501 | DEVICE COMBINING POSITIONING AND INJECTION SYSTEMS FOR INJECTION WITHIN A BODY CAVITY | July 2021 | January 2024 | Abandon | 30 | 1 | 0 | No | No |
| 17366231 | DOSE DETECTION SYSTEM MODULE FOR A MEDICATION DELIVERY DEVICE | July 2021 | August 2024 | Allow | 38 | 3 | 0 | Yes | No |
| 17303833 | CATHETER CONSTRUCTION | June 2021 | August 2023 | Allow | 27 | 1 | 0 | No | No |
| 17333161 | METHOD, SYSTEM AND COMPUTER PROGRAM PRODUCT FOR CGM-BASED PREVENTION OF HYPOGLYCEMIA VIA HYPOGLYCEMIA RISK ASSESSMENT AND SMOOTH REDUCTION INSULIN DELIVERY | May 2021 | August 2024 | Allow | 39 | 4 | 0 | Yes | No |
| 17328578 | BACTERIAL BIOFILM STAINING DEVICE AND METHODS OF USE | May 2021 | March 2025 | Abandon | 46 | 0 | 1 | No | No |
| 17323830 | DRUG DELIVERY DEVICE | May 2021 | June 2024 | Allow | 37 | 1 | 0 | No | No |
| 17323759 | MULTI-MODAL FIVE LUMEN GAS CIRCULATION SYSTEM FOR USE IN ENDOSCOPIC SURGICAL PROCEDURES | May 2021 | March 2024 | Allow | 34 | 3 | 0 | No | No |
| 17318432 | DRUG SUPPLY DEVICE | May 2021 | April 2024 | Abandon | 35 | 2 | 0 | No | No |
| 17240414 | Preloaded Stylet Valve Compatibility | April 2021 | July 2024 | Allow | 39 | 4 | 0 | No | Yes |
| 17236487 | Using Alternating Electric Fields to Increase Permeability of the Blood Brain Barrier | April 2021 | January 2025 | Allow | 45 | 3 | 0 | Yes | Yes |
| 17231939 | STEERABLE EXTENDABLE DEVICES | April 2021 | November 2023 | Abandon | 31 | 0 | 1 | No | No |
| 17227957 | CANNULA ASSEMBLY | April 2021 | August 2023 | Allow | 29 | 1 | 0 | No | No |
| 17274322 | LOCKING MECHANISM FOR A MODULAR ORGANIZATION SYSTEM | March 2021 | October 2024 | Allow | 43 | 2 | 0 | Yes | No |
| 17194108 | INJECTION PEN WITH DIAL BACK AND LAST DOSE CONTROL | March 2021 | March 2024 | Allow | 36 | 2 | 0 | Yes | No |
| 17194123 | INJECTION PEN WITH DIAL BACK AND LAST DOSE CONTROL | March 2021 | May 2024 | Allow | 39 | 3 | 0 | Yes | No |
| 17173003 | CATHETER CONSTRUCTION | February 2021 | August 2021 | Allow | 6 | 1 | 0 | Yes | No |
| 17160728 | KIT AND METHOD INTENDED FOR PROSTATE SURGERY | January 2021 | February 2024 | Allow | 36 | 2 | 0 | No | No |
| 17148757 | NEEDLE GUIDING SYSTEM | January 2021 | March 2025 | Allow | 50 | 4 | 1 | Yes | No |
| 17104685 | DRUG SOLUTION ADMINISTRATION METHOD | November 2020 | August 2023 | Allow | 32 | 2 | 0 | No | No |
| 17099161 | VASCULAR ACCESS PORT | November 2020 | March 2024 | Abandon | 40 | 3 | 0 | No | No |
| 17055229 | ADAPTIVE TRANSDERMAL IONTOPHORETIC INTRODUCTION SYSTEM FOR BEAUTY FIELD | November 2020 | June 2024 | Allow | 43 | 2 | 0 | No | No |
| 17052743 | ADJUSTABLE LENGTH NEEDLE HOUSING | November 2020 | June 2024 | Allow | 43 | 2 | 0 | Yes | No |
| 17082064 | DICLOFENAC AND HYALURONIC ACID COMBINATION TREATMENT FOR ORAL LEUKPOPLAKIA | October 2020 | October 2024 | Abandon | 48 | 1 | 0 | No | No |
| 17076158 | SYSTEM AND METHOD FOR MANAGING NOCTURNAL TREATMENT | October 2020 | September 2023 | Allow | 35 | 2 | 0 | Yes | No |
| 17073574 | System For Syringe Engagement To An Injector | October 2020 | May 2021 | Allow | 7 | 1 | 0 | Yes | No |
| 17048888 | A MEDICAL DEVICE FOR USE IN A NERVE BLOCK PROCEDURE THAT OBVIATES THE NEED FOR INJECTING TEST DOSES AND A METHOD | October 2020 | September 2024 | Allow | 47 | 3 | 0 | Yes | No |
| 17072864 | VALVE FOR DILATOR AND SHEATH ASSEMBLY | October 2020 | October 2023 | Allow | 36 | 2 | 0 | Yes | Yes |
| 17072421 | VALVE FOR DILATOR AND SHEATH ASSEMBLY | October 2020 | October 2023 | Allow | 36 | 2 | 0 | Yes | Yes |
| 17045708 | Flow Communication Unit With Unconnected and Connected Configuration | October 2020 | July 2024 | Allow | 45 | 2 | 0 | No | No |
| 17063228 | SENSOR FOR DETECTING TISSUE INFILTRATION | October 2020 | September 2023 | Allow | 36 | 1 | 1 | Yes | No |
| 17041886 | KIT AND METHOD OF REDUCING HUMAN ERROR DURING IMPLANTED INFUSION PUMP REFILLING | September 2020 | May 2024 | Abandon | 44 | 1 | 0 | No | No |
| 17024514 | BIFURCATED HUB | September 2020 | May 2025 | Allow | 56 | 4 | 0 | Yes | No |
| 17023746 | ENHANCED STYLET FOR DRUG DEPOT INJECTOR | September 2020 | May 2023 | Allow | 32 | 1 | 0 | Yes | No |
| 17003143 | MEDICAMENT DELIVERY DEVICE | August 2020 | October 2023 | Allow | 38 | 2 | 1 | No | No |
| 17001192 | TITRATION FOR MEDICAL INFUSION DEVICES AND SYSTEMS | August 2020 | April 2023 | Allow | 32 | 1 | 0 | No | No |
| 16988013 | CATHETER INSERTION DEVICE | August 2020 | February 2024 | Allow | 43 | 2 | 0 | No | No |
| 16983349 | SYSTEMS AND METHODS FOR CONTROLLING NEEDLE PENETRATION | August 2020 | May 2024 | Allow | 45 | 3 | 0 | No | No |
| 15733439 | RELEASABLE SAFETY CATHETER INSERTION ASSEMBLY | July 2020 | August 2022 | Abandon | 24 | 2 | 0 | No | Yes |
| 16965266 | HUB ASSEMBLY | July 2020 | August 2024 | Allow | 49 | 3 | 0 | Yes | No |
| 16961928 | THREE-WAY DEVICE FOR ANTI-BACKFLOW INFUSION AND DOSING | July 2020 | March 2024 | Abandon | 44 | 1 | 0 | No | No |
| 16957640 | PEN NEEDLE ASSEMBLY APPARATUS | June 2020 | November 2022 | Allow | 29 | 1 | 0 | Yes | No |
| 16908556 | SYSTEMS AND METHODS FOR PERFORMING MEDICAL PROCEDURES INVOLVING ACCESSING THE LYMPHATIC SYSTEM | June 2020 | August 2023 | Allow | 37 | 1 | 0 | No | No |
| 16902154 | CATHETER CONSTRUCTION | June 2020 | June 2021 | Allow | 12 | 1 | 1 | Yes | No |
| 16902159 | CATHETER CONSTRUCTIONS | June 2020 | November 2020 | Allow | 6 | 1 | 0 | Yes | No |
| 16771037 | IMPROVED SAFETY CATHETER NEEDLE | June 2020 | July 2021 | Allow | 14 | 1 | 0 | No | No |
| 16890580 | METHODS AND DEVICES FOR LOCALIZING COMPOSITIONS | June 2020 | January 2021 | Allow | 7 | 2 | 0 | No | No |
| 16874144 | Closed Tip Dynamic Microvalve Protection Device | May 2020 | March 2024 | Allow | 46 | 3 | 0 | No | No |
| 16869110 | Adductor Canal Block Introducer | May 2020 | July 2023 | Allow | 38 | 2 | 0 | Yes | No |
| 16761341 | Injection Device with a Preselector | May 2020 | November 2022 | Abandon | 31 | 1 | 0 | No | No |
| 16858348 | DISPOSABLE INTRAVENOUS (IV) SET WITH FLOW CONTROL VALVE | April 2020 | September 2023 | Allow | 41 | 2 | 0 | Yes | No |
| 16841903 | Adductor Canal Block Introducer | April 2020 | May 2023 | Abandon | 37 | 1 | 0 | No | No |
| 16825386 | STORAGE CONTAINER, PACKAGING MEMBER, AND MEDICAL INSTRUMENT SET | March 2020 | May 2023 | Allow | 38 | 1 | 0 | No | No |
| 16808784 | COMBINED DRUG DELIVERY METHODS AND APPARATUS | March 2020 | February 2023 | Allow | 35 | 1 | 0 | Yes | No |
| 16800841 | DEVICES AND METHODS FOR PROVIDING FOCAL COOLING TO THE BRAIN AND SPINAL CORD | February 2020 | May 2025 | Abandon | 60 | 6 | 1 | No | No |
| 16797598 | SELF-SEALING SEPTUM | February 2020 | June 2024 | Allow | 52 | 4 | 0 | Yes | No |
| 16789918 | CABLE ARRANGER | February 2020 | January 2023 | Abandon | 35 | 1 | 0 | No | No |
| 16637077 | INJECTOR DELAYED CARTRIDGE PIERCING MECHANISM | February 2020 | September 2022 | Allow | 32 | 1 | 0 | No | No |
| 16777361 | MEDICAL DEVICE FLUSHING SYSTEMS AND METHODS | January 2020 | February 2024 | Allow | 48 | 1 | 0 | Yes | No |
| 16634108 | ATTACHING/DETACHING DEVICE AND MULTI-DOSE INJECTION APPARATUS | January 2020 | April 2023 | Allow | 39 | 1 | 0 | Yes | No |
| 16732882 | Universal Portable Artificial Kidney for Hemodialysis and Peritoneal Dialysis | January 2020 | March 2023 | Allow | 38 | 2 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner DARB, HAMZA A..
With a 42.9% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 34.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner DARB, HAMZA A. works in Art Unit 3783 and has examined 335 patent applications in our dataset. With an allowance rate of 76.1%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 38 months.
Examiner DARB, HAMZA A.'s allowance rate of 76.1% places them in the 34% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by DARB, HAMZA A. receive 2.67 office actions before reaching final disposition. This places the examiner in the 89% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by DARB, HAMZA A. is 38 months. This places the examiner in the 13% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +35.4% benefit to allowance rate for applications examined by DARB, HAMZA A.. This interview benefit is in the 86% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 27.6% of applications are subsequently allowed. This success rate is in the 38% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 23.1% of cases where such amendments are filed. This entry rate is in the 22% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 127.3% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 83% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 82.5% of appeals filed. This is in the 73% percentile among all examiners. Of these withdrawals, 57.6% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 36.9% are granted (fully or in part). This grant rate is in the 33% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 43% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 42% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.